Patent · US Expired

Use of (S)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia

US5776911A · kind A · utility

3Cited by

0References

2Claims

0Family size

Assignee

Knoll, Inc. · DE

Inventor

Laszlo Szabo · Ditzingen, DE

Key dates

Filing date	Jan 16, 1997
Grant date	Jul 7, 1998
Priority date	—
Expiry date	Jan 16, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

SAMe and its physiologically tolerated salts are administered to a patient for the treatment of reperfusion damage caused by temporary focal ischemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.